IBL Healthcare Limited reported a stable performance for the quarter ended September 30, 2026
Filed as: Financial Results for the Quarter Ended Sep 2026
Summary
IBL Healthcare Limited reported a stable performance for the quarter ended September 30, 2026, with revenue of Rs 1.12 billion and net profit of Rs 64 million.
Read the original filingFigures in the filing
| Item | This period | Period before | Change |
|---|---|---|---|
| Revenue | 1.12B | 1.12B | +0.0% |
| Net Profit | 64.05M | 69.69M | -8.1% |
| Gross Profit | 391.85M | 400.09M | -2.1% |
| Cash and Bank Balances | 191.36M | 727.18M | -73.7% |
| Earnings Per Share (EPS) | 0.65 | 0.71 | -8.4% |
Amounts are in Pakistani rupees as stated in the filing (M = million, B = billion).
What the filing says
- Revenue remained stable at Rs 1.12 billion compared to the same period last year.
- Net profit decreased slightly to Rs 64 million from Rs 69.69 million in the prior year.
- Cash and bank balances decreased significantly to Rs 191 million from Rs 727 million as of June 30, 2026.
IBL HealthCare Limited (IBLHL) on Nafa
Last price Rs 41.00 · Pharmaceuticals · You can own IBLHL shares from your phone.
More IBLHL announcements
- NoticeRevised Presentation of Corporate Briefing Session held on November 02, 2026
- NoticeDissemination Of Video Recording Of Corporate Briefing Session - FY 2026
- NoticePresentation of Corporate Briefing Session 2026
- NoticeTransmission of Quarterly Report for the Period Ended Sep 2026
- NoticeNotice of Corporate Briefing Session
- NoticeCertified Copy of 29th Annual General Meeting Resolution
Source: IBL HealthCare Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.